UPDATED Apr 07, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GDDY | US$125.94 | 4.0% | 64.9% | US$17.9b | US$131.31 | PE13.1x | E-3.4% | n/a | Software | ||
CRBG | US$28.68 | 1.3% | 81.3% | US$17.9b | US$29.58 | PE16.2x | E23.7% | 3.2% | Diversified Financials | ||
LH | US$211.26 | -2.4% | -9.0% | US$17.8b | US$245.21 | PE46.9x | E24.1% | 1.4% | Healthcare | ||
AVTR | US$25.87 | 2.5% | 22.8% | US$17.6b | US$27.48 | PE54.7x | E27.2% | n/a | Pharmaceuticals & Biotech | ||
AVY | US$218.11 | -2.4% | 23.1% | US$17.6b | US$218.66 | PE34.9x | E12.6% | 1.5% | Materials | ||
CMS | US$58.65 | -2.2% | -5.3% | US$17.5b | US$62.46 | PE20x | E9.0% | 3.5% | Utilities | ||
PSTG | US$53.79 | 3.3% | 106.6% | US$17.5b | US$53.16 | PE285.1x | E49.6% | n/a | Tech | ||
RPRX | US$29.19 | -2.4% | -19.6% | US$17.4b | US$45.40 | PE11.5x | E5.9% | 2.9% | Pharmaceuticals & Biotech | ||
LDOS | US$128.66 | -1.3% | 38.9% | US$17.4b | US$139.41 | PE87.3x | E40.6% | 1.2% | Commercial Services | ||
WMG | US$33.33 | 0.8% | 3.8% | US$17.3b | US$39.20 | PE37.4x | E19.9% | 2.0% | Media | ||
BEKE | US$13.96 | -2.6% | -26.0% | US$17.2b | US$20.53 | PE21.2x | E9.1% | 2.5% | Real Estate Management and Development | ||
DKS | US$208.75 | -5.9% | 52.3% | US$17.2b | US$224.45 | PE16.4x | E2.5% | 2.1% | Retail | ||
BBY | US$79.61 | -2.5% | 6.2% | US$17.1b | US$86.15 | PE13.8x | E6.2% | 4.7% | Retail | ||
MRO | US$29.69 | 3.9% | 15.3% | US$17.1b | US$32.03 | PE11x | E-5.2% | 1.5% | Energy | ||
CVNA | US$83.84 | -3.4% | 800.5% | US$17.1b | US$62.86 | PE21.7x | E-9.3% | n/a | Retail | ||
AER | US$87.38 | 2.0% | 59.2% | US$17.1b | US$89.89 | PE5.5x | E-37.4% | n/a | Capital Goods | ||
JBL | US$140.47 | 3.6% | 69.1% | US$16.9b | US$148.29 | PE11.2x | E-15.2% | 0.2% | Tech | ||
SWKS | US$105.48 | -1.5% | -5.6% | US$16.9b | US$116.29 | PE18.7x | E10.7% | 2.6% | Semiconductors | ||
SYF | US$41.28 | -1.1% | 43.3% | US$16.8b | US$44.32 | PE7.6x | E3.1% | 2.4% | Diversified Financials | ||
PKG | US$187.67 | -0.6% | 33.1% | US$16.7b | US$169.63 | PE22x | E7.6% | 2.7% | Materials | ||
EG | US$379.86 | -4.6% | 4.1% | US$16.5b | US$424.55 | PE6.6x | E10.6% | 1.8% | Insurance | ||
TER | US$107.27 | -5.0% | 4.4% | US$16.4b | US$113.15 | PE36.6x | E20.7% | 0.4% | Semiconductors | ||
BMRN | US$86.95 | -0.2% | -11.3% | US$16.4b | US$109.83 | PE97.9x | E30.4% | n/a | Pharmaceuticals & Biotech | ||
AKAM | US$106.24 | -2.8% | 35.8% | US$16.3b | US$127.19 | PE29.7x | E13.7% | n/a | Software |